Sonnet BioTherapeutics Holdings's total assets for Q2 2025 were $3.84M, a decrease of -46.58% from the previous quarter. SONN total liabilities were $3.17M for the fiscal quarter, a 0.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.